Sort
8,912 grants matching “sars cov 2”
Leveraging Longitudinal Survey and EHR data to Dissect the Impact of COVID-19 related Stressors and Infections on Child Mental Health and Suicide Risks
$3,231,590Yunyu Xiao · Weill Medical Coll Of Cornell Univ · RF1 · FY2023 · MH
The Johns Hopkins Center for AIDS Research (JHU CFAR) RADx-UP
$3,222,658Richard E Chaisson · Johns Hopkins University · P30 · FY2020 · AI
Comparative Analysis Of Completely Sequenced Genomes
$3,221,620Eugene V Koonin · National Library Of Medicine · ZIA · FY2021 · LM
Modulation Of Neuronal Channels and Receptors in the Brain
$3,218,633Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC GY18
$3,200,000Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
Sleep and Neurodevelopment Service
$3,192,672Ashura Buckley · National Institute Of Mental Health · ZIA · FY2025 · MH
Impact of COVID-19 on AD Occurrence: A Biracial Intergenerational Population Study
$3,190,519Kumar B. Rajan · Rush University Medical Center · R01 · FY2021 · AG
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2 RESEARCH
$3,186,892Timothy Stedman · American Type Culture Collection · N01 · FY2023 · AI
Epigenomics and DNA Sequencing
$3,185,628Paul A Wade · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
Human monoclonal antibodies against SARS-CoV-2
$3,181,843Joshua Hoong Yu Tan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
THE PURPOSE OF THIS MODIFICATION IS TO ADD MILESTONE 1A, REVISE THE DELIVERABLES FOR MILESTONE 4-10, AND REVISE THE BASE POP TO END ON 1/18/2022.
$3,179,063Mark Marino · Venturewell · N02 · FY2021 · HL
Cross-Protective Humoral Immunity to Coronavirus
$3,175,901Duane R. Wesemann · Brigham And Women'S Hospital · P01 · FY2023 · AI
Cross-Protective Humoral Immunity to Coronavirus
$3,169,124Duane R. Wesemann · Brigham And Women'S Hospital · P01 · FY2021 · AI
Centers for Research on Structural Biology of Infectious Diseases: SARS-CoV-2
$3,166,598Peter Myler · Seattle Children'S Hospital · N01 · FY2024 · AI
RADX TECH - MAXIM BIOMEDICAL INC. SARS-COV-2 ANTIGEN RAPID TEST
$3,153,450Jonathan Maa · Maxim Biomedical, Inc. · N02 · FY2021 · HL
Tuberculosis Imaging Program
$3,147,878Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Administrative Core
$3,144,249Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2023 · AG
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)
$3,143,795Eugene M. Oltz · Ohio State University · U54 · FY2023 · CA
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
$3,123,720Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · AI
Developing novel strategies to increase COVID-19 testing among underserved and vulnerable populations in West Virginia through community and state partnerships
$3,103,241Sally Lynn Hodder · West Virginia University · U54 · FY2020 · GM
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients
$3,082,804Jonathan Kil · Sound Pharmaceuticals, Inc. · U01 · FY2021 · TR
Administrative Core
$3,077,212Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2024 · AG
Impact of COVID-19 on AD Occurrence: A Biracial Intergenerational Population Study
$3,073,401Kumar B. Rajan · Rush University Medical Center · R01 · FY2022 · AG
The Impact of the COVID-19 Pandemic on Severe Mental Illness
$3,072,053Nelson B Freimer · University Of California Los Angeles · RF1 · FY2023 · MH
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$3,069,641Adriana H Tremoulet · University Of California, San Diego · P50 · FY2022 · HD